# Summit Therapeutics Inc.: Form 8-K, filed Sep 12, 2024

- Company: [Summit Therapeutics Inc.](/companies/smmt.md) (CIK 1599298)
- Form: 8-K
- Filed: 2024-09-12
- Accepted by EDGAR: Sep 12, 2024, 10:49 ET
- Period: 2024-09-11
- Accession: 0001193125-24-217618
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1599298/000119312524217618/d799002d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1599298/000119312524217618/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1599298/000119312524217618/d799002d8k.htm

Filed Sep 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-217618. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.